Skip to main content

Advertisement

SpringerLink
Log in

New guidelines of the European society of hypertension

  • Invited Commentary
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mancia G, De Backer G, Dominiczak A, et al.: 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105–1187.

    Article  PubMed  CAS  Google Scholar 

  2. Mancia G, De Backer G, Dominiczak A, et al.: 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007, 28:1462–1536.

    PubMed  Google Scholar 

  3. Study rationale and design of ADVANCE: action in diabetes and vascular disease—preterax and diamicron MR controlled evaluation. Diabetologia 2001, 44:1118–1120.

  4. Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group: Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007, 370:829–840.

    Article  PubMed  CAS  Google Scholar 

  5. Granger CB, McMurray JJ, Yusuf S, et al.: Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 2003, 362:772–776.

    Article  PubMed  CAS  Google Scholar 

  6. McMurray JJ, Ostergren J, Swedberg K, et al.: Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 2003, 362:767–771.

    Article  PubMed  CAS  Google Scholar 

  7. Dahlöf B, Devereux RB, Kjeldsen SE, et al.: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002, 359:995–1003.

    Article  PubMed  Google Scholar 

  8. Teo K, Yusuf S, Sleight P, et al.: Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials. Am Heart J 2004, 148:52–61.

    Article  PubMed  Google Scholar 

  9. The ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, et al.: Telmisartan, ramipril or both in patients at high risk for vascular events. N Engl J Med 2008, 358:1547–1559.

    Article  PubMed  CAS  Google Scholar 

  10. Weber MA, Bakris GL, Dahlöf B, et al.: Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk. Blood Press 2007, 16:13–19.

    Article  PubMed  CAS  Google Scholar 

  11. Jamerson KA, on behalf of the ACCOMPLISH investigators: Avoiding cardiovascular events in combination therapy in patients living with systolic hypertension. Presented at the American College of Cardiology Scientific Sessions. Chicago, IL; March 31, 2008.

Download references

Author information

Authors and Affiliations

  1. Hypertension Unit, Hospital 12 de Octubre, Av. Córdoba s/n, 28041, Madrid, Spain

    Luis M. Ruilope

Authors
  1. Julian Segura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luis M. Ruilope
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luis M. Ruilope.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Segura, J., Ruilope, L.M. New guidelines of the European society of hypertension. Current Science Inc 10, 337–338 (2008). https://doi.org/10.1007/s11906-008-0062-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-008-0062-6

Keywords

Search

Navigation